Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

7TC9

Locally refined region of SARS-CoV-2 spike in complex with antibody A19-46.1

Summary for 7TC9
Entry DOI10.2210/pdb7tc9/pdb
EMDB information25806
DescriptorSpike protein S1, Heavy chain of antibody A19-46.1, Light chain of antibody A19-46.1, ... (4 entities in total)
Functional Keywordssars-cov-2, omicron, spike, antibody, viral protein, viral protein-immune system complex, viral protein/immune system
Biological sourceHomo sapiens (human)
More
Total number of polymer chains3
Total formula weight70034.46
Authors
Zhou, T.,Kwong, P.D. (deposition date: 2021-12-23, release date: 2022-03-30, Last modification date: 2024-11-20)
Primary citationZhou, T.,Wang, L.,Misasi, J.,Pegu, A.,Zhang, Y.,Harris, D.R.,Olia, A.S.,Talana, C.A.,Yang, E.S.,Chen, M.,Choe, M.,Shi, W.,Teng, I.T.,Creanga, A.,Jenkins, C.,Leung, K.,Liu, T.,Stancofski, E.D.,Stephens, T.,Zhang, B.,Tsybovsky, Y.,Graham, B.S.,Mascola, J.R.,Sullivan, N.J.,Kwong, P.D.
Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529.
Science, 376:eabn8897-eabn8897, 2022
Cited by
PubMed Abstract: The rapid spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.1.529 (Omicron) variant and its resistance to neutralization by vaccinee and convalescent sera are driving a search for monoclonal antibodies with potent neutralization. To provide insight into effective neutralization, we determined cryo-electron microscopy structures and evaluated receptor binding domain (RBD) antibodies for their ability to bind and neutralize B.1.1.529. Mutations altered 16% of the B.1.1.529 RBD surface, clustered on an RBD ridge overlapping the angiotensin-converting enzyme 2 (ACE2)-binding surface and reduced binding of most antibodies. Substantial inhibitory activity was retained by select monoclonal antibodies-including A23-58.1, B1-182.1, COV2-2196, S2E12, A19-46.1, S309, and LY-CoV1404-that accommodated these changes and neutralized B.1.1.529. We identified combinations of antibodies with synergistic neutralization. The analysis revealed structural mechanisms for maintenance of potent neutralization against emerging variants.
PubMed: 35324257
DOI: 10.1126/science.abn8897
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (5.08 Å)
Structure validation

227561

PDB entries from 2024-11-20

PDB statisticsPDBj update infoContact PDBjnumon